We demonstrated that DANCR, which is an oncogenic lncRNA in cervical cancer through activating the Wnt/β-catenin signaling pathway, might be a promising prognostic biomarker and therapeutic target for cervical cancer. This evidence concerns the gene DANCR and cervical cancer.